Long-term risk of mesenteric ischemia in patients with inflammatory bowel disease: a 13-year nationwide cohort study in an Asian population

Abstract Background It is unclear whether patients with inflammatory bowel disease (IBD) have higher risks of developing mesenteric ischemia. Methods We enrolled 9,363 patients who had been hospitalized because of IBD between January 1998 and December 2010, along with 37,452 control patients who wer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of surgery 2015-07, Vol.210 (1), p.80-86
Hauptverfasser: Tsai, Ming-Shian, M.D, Lin, Cheng-Li, M.Sc, Chen, Hsin-Pao, M.D, Lee, Po-Huang, M.D, Sung, Fung-Chang, Ph.D, Kao, Chia-Hung, M.D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background It is unclear whether patients with inflammatory bowel disease (IBD) have higher risks of developing mesenteric ischemia. Methods We enrolled 9,363 patients who had been hospitalized because of IBD between January 1998 and December 2010, along with 37,452 control patients who were matched at a 1:4 proportion for age, sex, and index year. We accounted the cumulative incidences and hazard ratios (HRs) of developing mesenteric ischemia during the 13-year study period. Results Patients with IBD had a considerably higher incidence rate of subsequent mesenteric ischemia compared with the controls (22.7 vs 3.09 per 10,000 person-years), with adjusted HR of 6.33 (95% confidence interval: 4.75 to 8.43). A multivariate stratified analysis showed that the mesenteric ischemia risk after adjustment for comorbidities is significantly higher in patients of all age groups, particularly in patients younger than 44 years (adjusted HR: 48.0; 95% confidence interval: 11.3 to 203.9). Moreover, patients with IBD were at highest risk of developing mesenteric ischemia within the first year of follow-up. Conclusions Careful follow-up and effective therapy are necessary to reduce the excessive risk in these patients.
ISSN:0002-9610
1879-1883
DOI:10.1016/j.amjsurg.2014.08.026